SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-156933
Filing Date
2016-11-14
Accepted
2016-11-14 16:37:32
Documents
3
Period of Report
2016-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-21623_18k.htm 8-K 22724
2 EX-99.1 a16-21623_1ex99d1.htm EX-99.1 70910
3 GRAPHIC g216231mmi001.jpg GRAPHIC 2917
  Complete submission text file 0001104659-16-156933.txt   98895
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 161995388
SIC: 2834 Pharmaceutical Preparations